272 related articles for article (PubMed ID: 22172593)
1. Neuroendocrine dysfunction in polycystic ovary syndrome.
Burt Solorzano CM; Beller JP; Abshire MY; Collins JS; McCartney CR; Marshall JC
Steroids; 2012 Mar; 77(4):332-7. PubMed ID: 22172593
[TBL] [Abstract][Full Text] [Related]
2. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
Blank SK; McCartney CR; Marshall JC
Hum Reprod Update; 2006; 12(4):351-61. PubMed ID: 16670102
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Blank SK; McCartney CR; Helm KD; Marshall JC
Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
[TBL] [Abstract][Full Text] [Related]
4. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
McCartney CR; Eagleson CA; Marshall JC
Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine aspects of polycystic ovary syndrome.
Marshall JC; Eagleson CA
Endocrinol Metab Clin North Am; 1999 Jun; 28(2):295-324. PubMed ID: 10352920
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine control in polycystic ovary-like syndrome.
Schoemaker J
Gynecol Endocrinol; 1991 Dec; 5(4):277-88. PubMed ID: 1796749
[TBL] [Abstract][Full Text] [Related]
7. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1994 Jul; 79(1):119-25. PubMed ID: 8027216
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
[TBL] [Abstract][Full Text] [Related]
9. Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.
Hayes FJ; Taylor AE; Martin KA; Hall JE
J Clin Endocrinol Metab; 1998 Jul; 83(7):2343-9. PubMed ID: 9661606
[TBL] [Abstract][Full Text] [Related]
10. Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome.
McGee WK; Bishop CV; Bahar A; Pohl CR; Chang RJ; Marshall JC; Pau FK; Stouffer RL; Cameron JL
Hum Reprod; 2012 Feb; 27(2):531-40. PubMed ID: 22114112
[TBL] [Abstract][Full Text] [Related]
11. The gonadotropic axis in hyperandrogenic adolescents.
Taylor AE
J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1281-4. PubMed ID: 11117670
[TBL] [Abstract][Full Text] [Related]
12. Pathological pulses in PCOS.
Coyle C; Campbell RE
Mol Cell Endocrinol; 2019 Dec; 498():110561. PubMed ID: 31461666
[TBL] [Abstract][Full Text] [Related]
13. Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity.
Rosenfield RL; Bordini B
Brain Res; 2010 Dec; 1364():186-97. PubMed ID: 20816944
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Pastor CL; Griffin-Korf ML; Aloi JA; Evans WS; Marshall JC
J Clin Endocrinol Metab; 1998 Feb; 83(2):582-90. PubMed ID: 9467578
[TBL] [Abstract][Full Text] [Related]
15. Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.
Cheung AP; Lu JK; Chang RJ
Hum Reprod; 1997 Jun; 12(6):1156-64. PubMed ID: 9221993
[TBL] [Abstract][Full Text] [Related]
16. Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models.
Roland AV; Moenter SM
Front Neuroendocrinol; 2014 Oct; 35(4):494-511. PubMed ID: 24747343
[TBL] [Abstract][Full Text] [Related]
17. Prenatal androgen excess enhances stimulation of the GNRH pulse in pubertal female rats.
Yan X; Yuan C; Zhao N; Cui Y; Liu J
J Endocrinol; 2014 Jul; 222(1):73-85. PubMed ID: 24829217
[TBL] [Abstract][Full Text] [Related]
18. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
19. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
Berga SL; Yen SS
Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984
[TBL] [Abstract][Full Text] [Related]
20. Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls.
Chhabra S; McCartney CR; Yoo RY; Eagleson CA; Chang RJ; Marshall JC
J Clin Endocrinol Metab; 2005 May; 90(5):2810-5. PubMed ID: 15728200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
